Triple
NDC Package 11086-021-06
Package Information
Triple is change wet and soiled diapers promptlyCleanse the diaper area and allow skin to dryApply ointment liberally as often as necessary, with each diaper change, especially at bedtime or any time exposure to wet diapers may be prolonged. Marketed by Summers Laboratories Inc, this product is identified by NDC 11086-021 and is authorized under FDA application M016.
Identification & Billing
- RxCUI: 637168 - zinc oxide 12.8 % Topical Ointment
- RxCUI: 637168 - zinc oxide 0.128 MG/MG Topical Ointment
- RxCUI: 637168 - ZNO 0.128 MG/MG Topical Ointment
- RxCUI: 729935 - TRIPLE PASTE 12.8 % Topical Ointment
- RxCUI: 729935 - zinc oxide 0.128 MG/MG Topical Ointment [Triple Paste]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11086 - Summers Laboratories Inc
- 11086-021 - Triple
- 11086-021-06 - 100 g in 1 PACKAGE
- 11086-021 - Triple
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11086-021). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11086-021-06 identifies a specific commercial package of 100 g in 1 package of Triple Medicated For Diaper Rash, labeled by Summers Laboratories Inc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Summers Laboratories Inc on October 30, 2013. The current certification is valid through December 31, 2024.
How is this Summers Laboratories Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11086002106. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.